Palareti, G. et al. 2022. Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results: The Apidulcis study. Bleeding, Thrombosis and Vascular Biology. 1, 1 (Mar. 2022). DOI:https://doi.org/10.4081/btvb.2022.10.